Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5

Details for Australian Patent Application No. 2004227833 (hide)

Owner Merck & Co., Inc.

Inventors Wang, Bowei; Roppe, Jeffrey R.; Cosford, Nicholas D. P.; Tehrani, Lida R.

Agent Spruson & Ferguson

Pub. Number AU-B-2004227833

PCT Pub. Number WO2004/089306

Priority 60/462,796 04.04.03 US

Filing date 31 March 2004

Wipo publication date 21 October 2004

Acceptance publication date 1 October 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/089306 Priority application(s): WO2004/089306

1 October 2009 Application Accepted

  Published as AU-B-2004227833

4 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227834-A filter for a cartridge, a cartridge, use of a filter in a cartridge and a system for preparing a liquid solution for a medical procedure

2004227832-Apparatus and method for supporting vertebral bodies